ADQUISICIÓN DEL PRODUCTO FARMACÉUTICO ONCOLÓGICO 2024- NO PNUME - RITUXIMAB 1400 mg /11.7 mL INY, ALECTINIB 150 mg TABLETA
Loading...
Create an account to explore this tender and find similar opportunities.